nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—ABCB1—melanoma	0.428	1	CbGaD
Rivaroxaban—CYP3A4—Temozolomide—melanoma	0.115	0.318	CbGbCtD
Rivaroxaban—ABCB1—Dactinomycin—melanoma	0.07	0.194	CbGbCtD
Rivaroxaban—CYP3A4—Vemurafenib—melanoma	0.0631	0.175	CbGbCtD
Rivaroxaban—CYP3A5—Docetaxel—melanoma	0.0555	0.154	CbGbCtD
Rivaroxaban—ABCB1—Docetaxel—melanoma	0.0362	0.0999	CbGbCtD
Rivaroxaban—CYP3A4—Docetaxel—melanoma	0.0217	0.0599	CbGbCtD
Rivaroxaban—Hemiparesis—Temozolomide—melanoma	0.00712	0.0446	CcSEcCtD
Rivaroxaban—Haemorrhage intracranial—Temozolomide—melanoma	0.00364	0.0228	CcSEcCtD
Rivaroxaban—Gamma-glutamyltransferase increased—Vemurafenib—melanoma	0.00355	0.0222	CcSEcCtD
Rivaroxaban—Cerebral haemorrhage—Carmustine—melanoma	0.00279	0.0175	CcSEcCtD
Rivaroxaban—Cerebral haemorrhage—Temozolomide—melanoma	0.0027	0.0169	CcSEcCtD
Rivaroxaban—Pain in extremity—Vemurafenib—melanoma	0.00212	0.0133	CcSEcCtD
Rivaroxaban—Menorrhagia—Temozolomide—melanoma	0.00202	0.0126	CcSEcCtD
Rivaroxaban—Cholestasis—Temozolomide—melanoma	0.00197	0.0123	CcSEcCtD
Rivaroxaban—Gamma-glutamyltransferase increased—Temozolomide—melanoma	0.00181	0.0113	CcSEcCtD
Rivaroxaban—Infestation NOS—Vemurafenib—melanoma	0.00163	0.0102	CcSEcCtD
Rivaroxaban—Infestation—Vemurafenib—melanoma	0.00163	0.0102	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00162	0.0101	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Vemurafenib—melanoma	0.00144	0.00902	CcSEcCtD
Rivaroxaban—Erythema multiforme—Vemurafenib—melanoma	0.00139	0.00867	CcSEcCtD
Rivaroxaban—Eye disorder—Vemurafenib—melanoma	0.00137	0.00857	CcSEcCtD
Rivaroxaban—Cardiac disorder—Vemurafenib—melanoma	0.00136	0.00851	CcSEcCtD
Rivaroxaban—Dermatitis atopic—Docetaxel—melanoma	0.00134	0.00839	CcSEcCtD
Rivaroxaban—Angiopathy—Vemurafenib—melanoma	0.00133	0.00832	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Vemurafenib—melanoma	0.00132	0.00827	CcSEcCtD
Rivaroxaban—Swelling—Carmustine—melanoma	0.00127	0.00795	CcSEcCtD
Rivaroxaban—Back pain—Vemurafenib—melanoma	0.00123	0.00772	CcSEcCtD
Rivaroxaban—Myocardial ischaemia—Docetaxel—melanoma	0.00123	0.00772	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00112	0.00701	CcSEcCtD
Rivaroxaban—Oropharyngeal pain—Docetaxel—melanoma	0.00109	0.00683	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00108	0.00675	CcSEcCtD
Rivaroxaban—Blood bilirubin increased—Docetaxel—melanoma	0.00105	0.00656	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Vemurafenib—melanoma	0.00104	0.00652	CcSEcCtD
Rivaroxaban—Infection—Vemurafenib—melanoma	0.00104	0.00648	CcSEcCtD
Rivaroxaban—Nervous system disorder—Vemurafenib—melanoma	0.00102	0.00639	CcSEcCtD
Rivaroxaban—Skin disorder—Vemurafenib—melanoma	0.00101	0.00633	CcSEcCtD
Rivaroxaban—Hypotension—Vemurafenib—melanoma	0.000974	0.00609	CcSEcCtD
Rivaroxaban—Haematuria—Bleomycin—melanoma	0.000944	0.0059	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000915	0.00572	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Vemurafenib—melanoma	0.000899	0.00563	CcSEcCtD
Rivaroxaban—Fatigue—Vemurafenib—melanoma	0.000898	0.00562	CcSEcCtD
Rivaroxaban—Haemoglobin—Bleomycin—melanoma	0.000893	0.00559	CcSEcCtD
Rivaroxaban—Constipation—Vemurafenib—melanoma	0.000891	0.00557	CcSEcCtD
Rivaroxaban—Haemorrhage—Bleomycin—melanoma	0.000888	0.00556	CcSEcCtD
Rivaroxaban—Agranulocytosis—Dactinomycin—melanoma	0.000861	0.00539	CcSEcCtD
Rivaroxaban—Renal failure—Carmustine—melanoma	0.000849	0.00531	CcSEcCtD
Rivaroxaban—Urinary tract infection—Carmustine—melanoma	0.00084	0.00525	CcSEcCtD
Rivaroxaban—Infestation NOS—Temozolomide—melanoma	0.000835	0.00522	CcSEcCtD
Rivaroxaban—Infestation—Temozolomide—melanoma	0.000835	0.00522	CcSEcCtD
Rivaroxaban—Hepatitis—Dactinomycin—melanoma	0.000829	0.00518	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000828	0.00518	CcSEcCtD
Rivaroxaban—Swelling—Docetaxel—melanoma	0.000817	0.00511	CcSEcCtD
Rivaroxaban—Urinary tract infection—Temozolomide—melanoma	0.000811	0.00508	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Temozolomide—melanoma	0.00079	0.00494	CcSEcCtD
Rivaroxaban—Erythema multiforme—Dactinomycin—melanoma	0.000783	0.0049	CcSEcCtD
Rivaroxaban—Sinusitis—Temozolomide—melanoma	0.000783	0.0049	CcSEcCtD
Rivaroxaban—Haemoglobin—Carmustine—melanoma	0.000779	0.00488	CcSEcCtD
Rivaroxaban—Haemorrhage—Carmustine—melanoma	0.000776	0.00485	CcSEcCtD
Rivaroxaban—Hypersensitivity—Vemurafenib—melanoma	0.000768	0.0048	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Carmustine—melanoma	0.000762	0.00477	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Docetaxel—melanoma	0.000754	0.00472	CcSEcCtD
Rivaroxaban—Haemoglobin—Temozolomide—melanoma	0.000753	0.00471	CcSEcCtD
Rivaroxaban—Haemorrhage—Temozolomide—melanoma	0.000749	0.00469	CcSEcCtD
Rivaroxaban—Hepatitis—Temozolomide—melanoma	0.000749	0.00469	CcSEcCtD
Rivaroxaban—Asthenia—Vemurafenib—melanoma	0.000747	0.00468	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Temozolomide—melanoma	0.00074	0.00463	CcSEcCtD
Rivaroxaban—Pruritus—Vemurafenib—melanoma	0.000737	0.00461	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Temozolomide—melanoma	0.000736	0.00461	CcSEcCtD
Rivaroxaban—Urethral disorder—Temozolomide—melanoma	0.000735	0.0046	CcSEcCtD
Rivaroxaban—Eye disorder—Carmustine—melanoma	0.000725	0.00453	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00072	0.00451	CcSEcCtD
Rivaroxaban—Pain in extremity—Docetaxel—melanoma	0.00072	0.00451	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Bleomycin—melanoma	0.000718	0.00449	CcSEcCtD
Rivaroxaban—Anaemia—Bleomycin—melanoma	0.000715	0.00447	CcSEcCtD
Rivaroxaban—Diarrhoea—Vemurafenib—melanoma	0.000713	0.00446	CcSEcCtD
Rivaroxaban—Erythema multiforme—Temozolomide—melanoma	0.000709	0.00443	CcSEcCtD
Rivaroxaban—Eye disorder—Temozolomide—melanoma	0.0007	0.00438	CcSEcCtD
Rivaroxaban—Malaise—Bleomycin—melanoma	0.000697	0.00436	CcSEcCtD
Rivaroxaban—Cardiac disorder—Temozolomide—melanoma	0.000696	0.00435	CcSEcCtD
Rivaroxaban—Dizziness—Vemurafenib—melanoma	0.000689	0.00431	CcSEcCtD
Rivaroxaban—Angiopathy—Temozolomide—melanoma	0.00068	0.00425	CcSEcCtD
Rivaroxaban—Immune system disorder—Temozolomide—melanoma	0.000677	0.00423	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Temozolomide—melanoma	0.000675	0.00423	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Dactinomycin—melanoma	0.000669	0.00419	CcSEcCtD
Rivaroxaban—Anaemia—Dactinomycin—melanoma	0.000667	0.00417	CcSEcCtD
Rivaroxaban—Vomiting—Vemurafenib—melanoma	0.000662	0.00414	CcSEcCtD
Rivaroxaban—Chest pain—Bleomycin—melanoma	0.000658	0.00412	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Docetaxel—melanoma	0.000658	0.00412	CcSEcCtD
Rivaroxaban—Rash—Vemurafenib—melanoma	0.000657	0.00411	CcSEcCtD
Rivaroxaban—Dermatitis—Vemurafenib—melanoma	0.000656	0.00411	CcSEcCtD
Rivaroxaban—Back pain—Carmustine—melanoma	0.000653	0.00409	CcSEcCtD
Rivaroxaban—Headache—Vemurafenib—melanoma	0.000653	0.00408	CcSEcCtD
Rivaroxaban—Discomfort—Bleomycin—melanoma	0.000651	0.00407	CcSEcCtD
Rivaroxaban—Malaise—Dactinomycin—melanoma	0.00065	0.00407	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Bleomycin—melanoma	0.000631	0.00395	CcSEcCtD
Rivaroxaban—Oedema—Bleomycin—melanoma	0.000631	0.00395	CcSEcCtD
Rivaroxaban—Back pain—Temozolomide—melanoma	0.000631	0.00395	CcSEcCtD
Rivaroxaban—Infection—Bleomycin—melanoma	0.000627	0.00392	CcSEcCtD
Rivaroxaban—Anaemia—Carmustine—melanoma	0.000624	0.0039	CcSEcCtD
Rivaroxaban—Nausea—Vemurafenib—melanoma	0.000619	0.00387	CcSEcCtD
Rivaroxaban—Discomfort—Dactinomycin—melanoma	0.000607	0.0038	CcSEcCtD
Rivaroxaban—Angina pectoris—Docetaxel—melanoma	0.000607	0.00379	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Temozolomide—melanoma	0.000605	0.00379	CcSEcCtD
Rivaroxaban—Anaemia—Temozolomide—melanoma	0.000603	0.00377	CcSEcCtD
Rivaroxaban—Angioedema—Temozolomide—melanoma	0.000596	0.00373	CcSEcCtD
Rivaroxaban—Hypotension—Bleomycin—melanoma	0.00059	0.00369	CcSEcCtD
Rivaroxaban—Oedema—Dactinomycin—melanoma	0.000589	0.00368	CcSEcCtD
Rivaroxaban—Malaise—Temozolomide—melanoma	0.000588	0.00368	CcSEcCtD
Rivaroxaban—Infection—Dactinomycin—melanoma	0.000585	0.00366	CcSEcCtD
Rivaroxaban—Chest pain—Carmustine—melanoma	0.000575	0.0036	CcSEcCtD
Rivaroxaban—Dyspnoea—Bleomycin—melanoma	0.000563	0.00352	CcSEcCtD
Rivaroxaban—Infestation—Docetaxel—melanoma	0.000555	0.00347	CcSEcCtD
Rivaroxaban—Infestation NOS—Docetaxel—melanoma	0.000555	0.00347	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000552	0.00345	CcSEcCtD
Rivaroxaban—Oedema—Carmustine—melanoma	0.000551	0.00345	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00055	0.00344	CcSEcCtD
Rivaroxaban—Discomfort—Temozolomide—melanoma	0.000549	0.00343	CcSEcCtD
Rivaroxaban—Infection—Carmustine—melanoma	0.000547	0.00342	CcSEcCtD
Rivaroxaban—Renal failure—Docetaxel—melanoma	0.000546	0.00341	CcSEcCtD
Rivaroxaban—Dry mouth—Temozolomide—melanoma	0.000543	0.0034	CcSEcCtD
Rivaroxaban—Jaundice—Docetaxel—melanoma	0.000541	0.00339	CcSEcCtD
Rivaroxaban—Pain—Bleomycin—melanoma	0.00054	0.00338	CcSEcCtD
Rivaroxaban—Tachycardia—Carmustine—melanoma	0.000538	0.00336	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Temozolomide—melanoma	0.000532	0.00333	CcSEcCtD
Rivaroxaban—Oedema—Temozolomide—melanoma	0.000532	0.00333	CcSEcCtD
Rivaroxaban—Infection—Temozolomide—melanoma	0.000529	0.00331	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Docetaxel—melanoma	0.000525	0.00328	CcSEcCtD
Rivaroxaban—Epistaxis—Docetaxel—melanoma	0.000524	0.00328	CcSEcCtD
Rivaroxaban—Nervous system disorder—Temozolomide—melanoma	0.000522	0.00327	CcSEcCtD
Rivaroxaban—Feeling abnormal—Bleomycin—melanoma	0.00052	0.00325	CcSEcCtD
Rivaroxaban—Agranulocytosis—Docetaxel—melanoma	0.000518	0.00324	CcSEcCtD
Rivaroxaban—Skin disorder—Temozolomide—melanoma	0.000517	0.00324	CcSEcCtD
Rivaroxaban—Hypotension—Carmustine—melanoma	0.000515	0.00322	CcSEcCtD
Rivaroxaban—Fatigue—Dactinomycin—melanoma	0.000508	0.00318	CcSEcCtD
Rivaroxaban—Pain—Dactinomycin—melanoma	0.000503	0.00315	CcSEcCtD
Rivaroxaban—Urticaria—Bleomycin—melanoma	0.000501	0.00314	CcSEcCtD
Rivaroxaban—Haemoglobin—Docetaxel—melanoma	0.000501	0.00313	CcSEcCtD
Rivaroxaban—Haemorrhage—Docetaxel—melanoma	0.000498	0.00312	CcSEcCtD
Rivaroxaban—Hepatitis—Docetaxel—melanoma	0.000498	0.00312	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Docetaxel—melanoma	0.000492	0.00308	CcSEcCtD
Rivaroxaban—Dyspnoea—Carmustine—melanoma	0.000491	0.00307	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Docetaxel—melanoma	0.00049	0.00306	CcSEcCtD
Rivaroxaban—Urethral disorder—Docetaxel—melanoma	0.000489	0.00306	CcSEcCtD
Rivaroxaban—Feeling abnormal—Dactinomycin—melanoma	0.000485	0.00303	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Dactinomycin—melanoma	0.000481	0.00301	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Carmustine—melanoma	0.000476	0.00298	CcSEcCtD
Rivaroxaban—Dyspnoea—Temozolomide—melanoma	0.000475	0.00297	CcSEcCtD
Rivaroxaban—Erythema multiforme—Docetaxel—melanoma	0.000471	0.00295	CcSEcCtD
Rivaroxaban—Pain—Carmustine—melanoma	0.000471	0.00295	CcSEcCtD
Rivaroxaban—Constipation—Carmustine—melanoma	0.000471	0.00295	CcSEcCtD
Rivaroxaban—Dyspepsia—Temozolomide—melanoma	0.000469	0.00293	CcSEcCtD
Rivaroxaban—Eye disorder—Docetaxel—melanoma	0.000466	0.00291	CcSEcCtD
Rivaroxaban—Abdominal pain—Dactinomycin—melanoma	0.000465	0.00291	CcSEcCtD
Rivaroxaban—Hypersensitivity—Bleomycin—melanoma	0.000465	0.00291	CcSEcCtD
Rivaroxaban—Cardiac disorder—Docetaxel—melanoma	0.000463	0.00289	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Temozolomide—melanoma	0.00046	0.00288	CcSEcCtD
Rivaroxaban—Fatigue—Temozolomide—melanoma	0.000459	0.00287	CcSEcCtD
Rivaroxaban—Pain—Temozolomide—melanoma	0.000455	0.00285	CcSEcCtD
Rivaroxaban—Constipation—Temozolomide—melanoma	0.000455	0.00285	CcSEcCtD
Rivaroxaban—Feeling abnormal—Carmustine—melanoma	0.000454	0.00284	CcSEcCtD
Rivaroxaban—Asthenia—Bleomycin—melanoma	0.000453	0.00283	CcSEcCtD
Rivaroxaban—Angiopathy—Docetaxel—melanoma	0.000452	0.00283	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Carmustine—melanoma	0.000451	0.00282	CcSEcCtD
Rivaroxaban—Immune system disorder—Docetaxel—melanoma	0.00045	0.00282	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Docetaxel—melanoma	0.000449	0.00281	CcSEcCtD
Rivaroxaban—Pruritus—Bleomycin—melanoma	0.000447	0.00279	CcSEcCtD
Rivaroxaban—Feeling abnormal—Temozolomide—melanoma	0.000439	0.00274	CcSEcCtD
Rivaroxaban—Abdominal pain—Carmustine—melanoma	0.000436	0.00272	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Temozolomide—melanoma	0.000435	0.00272	CcSEcCtD
Rivaroxaban—Hypersensitivity—Dactinomycin—melanoma	0.000434	0.00271	CcSEcCtD
Rivaroxaban—Urticaria—Temozolomide—melanoma	0.000423	0.00265	CcSEcCtD
Rivaroxaban—Asthenia—Dactinomycin—melanoma	0.000422	0.00264	CcSEcCtD
Rivaroxaban—Abdominal pain—Temozolomide—melanoma	0.000421	0.00263	CcSEcCtD
Rivaroxaban—Back pain—Docetaxel—melanoma	0.00042	0.00263	CcSEcCtD
Rivaroxaban—Muscle spasms—Docetaxel—melanoma	0.000417	0.00261	CcSEcCtD
Rivaroxaban—Hypersensitivity—Carmustine—melanoma	0.000406	0.00254	CcSEcCtD
Rivaroxaban—Diarrhoea—Dactinomycin—melanoma	0.000403	0.00252	CcSEcCtD
Rivaroxaban—Vomiting—Bleomycin—melanoma	0.000401	0.00251	CcSEcCtD
Rivaroxaban—Anaemia—Docetaxel—melanoma	0.000401	0.00251	CcSEcCtD
Rivaroxaban—Rash—Bleomycin—melanoma	0.000398	0.00249	CcSEcCtD
Rivaroxaban—Dermatitis—Bleomycin—melanoma	0.000398	0.00249	CcSEcCtD
Rivaroxaban—Asthenia—Carmustine—melanoma	0.000395	0.00247	CcSEcCtD
Rivaroxaban—Hypersensitivity—Temozolomide—melanoma	0.000392	0.00245	CcSEcCtD
Rivaroxaban—Syncope—Docetaxel—melanoma	0.000389	0.00243	CcSEcCtD
Rivaroxaban—Asthenia—Temozolomide—melanoma	0.000382	0.00239	CcSEcCtD
Rivaroxaban—Loss of consciousness—Docetaxel—melanoma	0.000381	0.00239	CcSEcCtD
Rivaroxaban—Diarrhoea—Carmustine—melanoma	0.000377	0.00236	CcSEcCtD
Rivaroxaban—Pruritus—Temozolomide—melanoma	0.000377	0.00236	CcSEcCtD
Rivaroxaban—Nausea—Bleomycin—melanoma	0.000375	0.00235	CcSEcCtD
Rivaroxaban—Vomiting—Dactinomycin—melanoma	0.000374	0.00234	CcSEcCtD
Rivaroxaban—Rash—Dactinomycin—melanoma	0.000371	0.00232	CcSEcCtD
Rivaroxaban—Chest pain—Docetaxel—melanoma	0.000369	0.00231	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000367	0.00229	CcSEcCtD
Rivaroxaban—Dizziness—Carmustine—melanoma	0.000364	0.00228	CcSEcCtD
Rivaroxaban—Diarrhoea—Temozolomide—melanoma	0.000364	0.00228	CcSEcCtD
Rivaroxaban—Dry mouth—Docetaxel—melanoma	0.000361	0.00226	CcSEcCtD
Rivaroxaban—Oedema—Docetaxel—melanoma	0.000354	0.00222	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Docetaxel—melanoma	0.000354	0.00222	CcSEcCtD
Rivaroxaban—Dizziness—Temozolomide—melanoma	0.000352	0.0022	CcSEcCtD
Rivaroxaban—Infection—Docetaxel—melanoma	0.000352	0.0022	CcSEcCtD
Rivaroxaban—Vomiting—Carmustine—melanoma	0.00035	0.00219	CcSEcCtD
Rivaroxaban—Nausea—Dactinomycin—melanoma	0.00035	0.00219	CcSEcCtD
Rivaroxaban—Shock—Docetaxel—melanoma	0.000348	0.00218	CcSEcCtD
Rivaroxaban—Rash—Carmustine—melanoma	0.000347	0.00217	CcSEcCtD
Rivaroxaban—Nervous system disorder—Docetaxel—melanoma	0.000347	0.00217	CcSEcCtD
Rivaroxaban—Dermatitis—Carmustine—melanoma	0.000347	0.00217	CcSEcCtD
Rivaroxaban—Tachycardia—Docetaxel—melanoma	0.000346	0.00216	CcSEcCtD
Rivaroxaban—Headache—Carmustine—melanoma	0.000345	0.00216	CcSEcCtD
Rivaroxaban—Skin disorder—Docetaxel—melanoma	0.000344	0.00215	CcSEcCtD
Rivaroxaban—Vomiting—Temozolomide—melanoma	0.000339	0.00212	CcSEcCtD
Rivaroxaban—Rash—Temozolomide—melanoma	0.000336	0.0021	CcSEcCtD
Rivaroxaban—Dermatitis—Temozolomide—melanoma	0.000335	0.0021	CcSEcCtD
Rivaroxaban—Headache—Temozolomide—melanoma	0.000334	0.00209	CcSEcCtD
Rivaroxaban—Hypotension—Docetaxel—melanoma	0.000331	0.00207	CcSEcCtD
Rivaroxaban—Nausea—Carmustine—melanoma	0.000327	0.00205	CcSEcCtD
Rivaroxaban—Nausea—Temozolomide—melanoma	0.000316	0.00198	CcSEcCtD
Rivaroxaban—Dyspnoea—Docetaxel—melanoma	0.000316	0.00197	CcSEcCtD
Rivaroxaban—Dyspepsia—Docetaxel—melanoma	0.000312	0.00195	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Docetaxel—melanoma	0.000306	0.00191	CcSEcCtD
Rivaroxaban—Fatigue—Docetaxel—melanoma	0.000305	0.00191	CcSEcCtD
Rivaroxaban—Pain—Docetaxel—melanoma	0.000303	0.00189	CcSEcCtD
Rivaroxaban—Constipation—Docetaxel—melanoma	0.000303	0.00189	CcSEcCtD
Rivaroxaban—Feeling abnormal—Docetaxel—melanoma	0.000292	0.00183	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Docetaxel—melanoma	0.00029	0.00181	CcSEcCtD
Rivaroxaban—Abdominal pain—Docetaxel—melanoma	0.00028	0.00175	CcSEcCtD
Rivaroxaban—Hypersensitivity—Docetaxel—melanoma	0.000261	0.00163	CcSEcCtD
Rivaroxaban—Asthenia—Docetaxel—melanoma	0.000254	0.00159	CcSEcCtD
Rivaroxaban—Pruritus—Docetaxel—melanoma	0.000251	0.00157	CcSEcCtD
Rivaroxaban—Diarrhoea—Docetaxel—melanoma	0.000242	0.00152	CcSEcCtD
Rivaroxaban—Dizziness—Docetaxel—melanoma	0.000234	0.00146	CcSEcCtD
Rivaroxaban—Vomiting—Docetaxel—melanoma	0.000225	0.00141	CcSEcCtD
Rivaroxaban—Rash—Docetaxel—melanoma	0.000223	0.0014	CcSEcCtD
Rivaroxaban—Dermatitis—Docetaxel—melanoma	0.000223	0.0014	CcSEcCtD
Rivaroxaban—Headache—Docetaxel—melanoma	0.000222	0.00139	CcSEcCtD
Rivaroxaban—Nausea—Docetaxel—melanoma	0.00021	0.00132	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—CSPG4—melanoma	0.0001	0.00197	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—BSG—melanoma	0.0001	0.00197	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—ITGB3—melanoma	0.0001	0.00197	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PRKCA—melanoma	0.0001	0.00197	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL10—melanoma	9.99e-05	0.00196	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	9.72e-05	0.00191	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GPAM—melanoma	9.72e-05	0.00191	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL4—melanoma	9.71e-05	0.00191	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	9.66e-05	0.0019	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	9.59e-05	0.00189	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—PDGFRA—melanoma	9.56e-05	0.00188	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-B—melanoma	9.5e-05	0.00187	CbGpPWpGaD
Rivaroxaban—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	9.46e-05	0.00186	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	9.38e-05	0.00185	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	9.36e-05	0.00184	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—FASLG—melanoma	9.28e-05	0.00183	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—RAC1—melanoma	9.28e-05	0.00183	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	9.24e-05	0.00182	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—MMP1—melanoma	8.98e-05	0.00177	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—FAS—melanoma	8.95e-05	0.00176	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	8.89e-05	0.00175	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—CYP1B1—melanoma	8.88e-05	0.00175	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	8.84e-05	0.00174	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CDK2—melanoma	8.81e-05	0.00173	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-A—melanoma	8.8e-05	0.00173	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—CYP1B1—melanoma	8.76e-05	0.00172	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	8.73e-05	0.00172	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	8.66e-05	0.0017	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PLA2G6—melanoma	8.26e-05	0.00163	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—FN1—melanoma	8.19e-05	0.00161	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NOS2—melanoma	8.09e-05	0.00159	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	8.04e-05	0.00158	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PIK3CG—melanoma	7.84e-05	0.00154	CbGpPWpGaD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	7.81e-05	0.00154	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	7.77e-05	0.00153	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—EGF—melanoma	7.75e-05	0.00152	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CD80—melanoma	7.43e-05	0.00146	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—VCAN—melanoma	7.42e-05	0.00146	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IGF1—melanoma	7.18e-05	0.00141	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—MMP1—melanoma	7.06e-05	0.00139	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.03e-05	0.00138	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CASP8—melanoma	6.91e-05	0.00136	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PIK3CD—melanoma	6.89e-05	0.00136	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—ALB—melanoma	6.8e-05	0.00134	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.78e-05	0.00133	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	6.61e-05	0.0013	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	6.37e-05	0.00125	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP17A1—melanoma	6.26e-05	0.00123	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.18e-05	0.00122	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—melanoma	6.1e-05	0.0012	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PIK3CB—melanoma	6.01e-05	0.00118	CbGpPWpGaD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	5.98e-05	0.00118	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ACER3—melanoma	5.92e-05	0.00116	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GNA11—melanoma	5.91e-05	0.00116	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IFNG—melanoma	5.87e-05	0.00116	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—FASN—melanoma	5.79e-05	0.00114	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	5.78e-05	0.00114	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—SLC5A5—melanoma	5.69e-05	0.00112	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—IGF1—melanoma	5.65e-05	0.00111	CbGpPWpGaD
Rivaroxaban—CYP3A4—Tryptophan metabolism—MDM2—melanoma	5.55e-05	0.00109	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IL2—melanoma	5.52e-05	0.00109	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CD44—melanoma	5.5e-05	0.00108	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GNAQ—melanoma	5.5e-05	0.00108	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—MMP2—melanoma	5.46e-05	0.00107	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CXCL8—melanoma	5.46e-05	0.00107	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—UGT2B10—melanoma	5.42e-05	0.00107	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.38e-05	0.00106	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.33e-05	0.00105	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP1B1—melanoma	5.27e-05	0.00104	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CASP3—melanoma	5.23e-05	0.00103	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL2—melanoma	5.22e-05	0.00103	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	5.2e-05	0.00102	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	5.12e-05	0.00101	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HS3ST5—melanoma	5.04e-05	0.000991	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP17A1—melanoma	4.91e-05	0.000965	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	4.87e-05	0.000959	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	4.84e-05	0.000952	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	4.77e-05	0.000938	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	4.72e-05	0.000928	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—VEGFA—melanoma	4.69e-05	0.000922	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	4.67e-05	0.000919	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.65e-05	0.000915	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NRAS—melanoma	4.63e-05	0.000911	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	4.58e-05	0.000901	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CXCL8—melanoma	4.54e-05	0.000893	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	4.5e-05	0.000885	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ACER3—melanoma	4.47e-05	0.000879	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—MAPK3—melanoma	4.44e-05	0.000872	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—VEGFA—melanoma	4.43e-05	0.000872	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	4.42e-05	0.000869	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ABCB1—melanoma	4.34e-05	0.000854	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	4.33e-05	0.000852	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—MAPK1—melanoma	4.22e-05	0.00083	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CTNNB1—melanoma	4.19e-05	0.000824	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP1B1—melanoma	4.13e-05	0.000812	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	4.11e-05	0.000809	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—UGT2B10—melanoma	4.09e-05	0.000804	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	4.07e-05	0.000801	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PRKCA—melanoma	3.99e-05	0.000786	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—KRAS—melanoma	3.99e-05	0.000784	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ERCC2—melanoma	3.96e-05	0.000779	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	3.9e-05	0.000768	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	3.89e-05	0.000765	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLCB4—melanoma	3.82e-05	0.000751	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—melanoma	3.8e-05	0.000748	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HS3ST5—melanoma	3.8e-05	0.000747	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PIK3CA—melanoma	3.66e-05	0.00072	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	3.66e-05	0.00072	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	3.62e-05	0.000712	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIP4K2A—melanoma	3.59e-05	0.000706	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC6A11—melanoma	3.59e-05	0.000706	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TP53—melanoma	3.54e-05	0.000697	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTAP—melanoma	3.49e-05	0.000687	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	3.41e-05	0.00067	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—HRAS—melanoma	3.39e-05	0.000666	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	3.35e-05	0.000659	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.28e-05	0.000646	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	3.27e-05	0.000643	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	3.24e-05	0.000637	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CG—melanoma	3.13e-05	0.000616	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LUM—melanoma	3.11e-05	0.000612	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PHGDH—melanoma	3.11e-05	0.000612	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	3.08e-05	0.000606	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HPSE—melanoma	3.05e-05	0.0006	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARG—melanoma	3.02e-05	0.000594	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CUBN—melanoma	2.99e-05	0.000589	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—AKT1—melanoma	2.99e-05	0.000588	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	2.92e-05	0.000575	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SDHD—melanoma	2.89e-05	0.000569	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—BSG—melanoma	2.89e-05	0.000569	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CSPG4—melanoma	2.89e-05	0.000569	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	2.88e-05	0.000567	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLCB4—melanoma	2.88e-05	0.000566	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	2.84e-05	0.000559	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GPAM—melanoma	2.8e-05	0.000551	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	2.78e-05	0.000547	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ACER3—melanoma	2.75e-05	0.000542	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CD—melanoma	2.75e-05	0.000541	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALB—melanoma	2.72e-05	0.000534	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC6A11—melanoma	2.71e-05	0.000533	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIP4K2A—melanoma	2.71e-05	0.000533	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.64e-05	0.00052	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTAP—melanoma	2.63e-05	0.000518	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.63e-05	0.000518	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.58e-05	0.000507	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—UGT2B10—melanoma	2.52e-05	0.000495	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.51e-05	0.000494	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.49e-05	0.000489	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	2.43e-05	0.000478	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	2.42e-05	0.000477	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	2.41e-05	0.000474	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CB—melanoma	2.4e-05	0.000472	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLA2G6—melanoma	2.38e-05	0.000469	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—melanoma	2.38e-05	0.000467	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LUM—melanoma	2.35e-05	0.000462	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PHGDH—melanoma	2.35e-05	0.000462	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HS3ST5—melanoma	2.34e-05	0.000461	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HPSE—melanoma	2.3e-05	0.000453	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CUBN—melanoma	2.26e-05	0.000445	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	2.19e-05	0.000431	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SDHD—melanoma	2.18e-05	0.000429	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—BSG—melanoma	2.18e-05	0.000429	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CSPG4—melanoma	2.18e-05	0.000429	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—VCAN—melanoma	2.14e-05	0.000421	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPAM—melanoma	2.11e-05	0.000416	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTEN—melanoma	2.07e-05	0.000408	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	2.07e-05	0.000407	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	2.01e-05	0.000396	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.97e-05	0.000387	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.97e-05	0.000387	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.88e-05	0.000369	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.86e-05	0.000366	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP17A1—melanoma	1.8e-05	0.000355	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLA2G6—melanoma	1.8e-05	0.000354	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLCB4—melanoma	1.77e-05	0.000349	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.71e-05	0.000336	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GNA11—melanoma	1.7e-05	0.000335	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC6A11—melanoma	1.67e-05	0.000328	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIP4K2A—melanoma	1.67e-05	0.000328	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—FASN—melanoma	1.67e-05	0.000328	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.65e-05	0.000325	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC5A5—melanoma	1.64e-05	0.000323	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTAP—melanoma	1.62e-05	0.000319	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—VCAN—melanoma	1.61e-05	0.000318	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GNAQ—melanoma	1.58e-05	0.000312	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CD44—melanoma	1.58e-05	0.000312	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP1B1—melanoma	1.52e-05	0.000299	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CA—melanoma	1.46e-05	0.000288	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LUM—melanoma	1.45e-05	0.000285	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PHGDH—melanoma	1.45e-05	0.000285	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HPSE—melanoma	1.42e-05	0.000279	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.4e-05	0.000275	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CUBN—melanoma	1.39e-05	0.000274	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP17A1—melanoma	1.36e-05	0.000268	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SDHD—melanoma	1.34e-05	0.000264	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—BSG—melanoma	1.34e-05	0.000264	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CSPG4—melanoma	1.34e-05	0.000264	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPAM—melanoma	1.3e-05	0.000256	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GNA11—melanoma	1.29e-05	0.000253	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.26e-05	0.000248	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FASN—melanoma	1.26e-05	0.000248	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCB1—melanoma	1.25e-05	0.000246	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC5A5—melanoma	1.24e-05	0.000244	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GNAQ—melanoma	1.2e-05	0.000235	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CD44—melanoma	1.2e-05	0.000235	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AKT1—melanoma	1.19e-05	0.000235	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PRKCA—melanoma	1.15e-05	0.000226	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP1B1—melanoma	1.15e-05	0.000226	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ERCC2—melanoma	1.14e-05	0.000225	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLA2G6—melanoma	1.11e-05	0.000218	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—VCAN—melanoma	9.95e-06	0.000196	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CG—melanoma	9.02e-06	0.000177	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—melanoma	8.7e-06	0.000171	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PRKCA—melanoma	8.69e-06	0.000171	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ERCC2—melanoma	8.62e-06	0.00017	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP17A1—melanoma	8.39e-06	0.000165	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CD—melanoma	7.93e-06	0.000156	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GNA11—melanoma	7.92e-06	0.000156	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—melanoma	7.83e-06	0.000154	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FASN—melanoma	7.75e-06	0.000153	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC5A5—melanoma	7.63e-06	0.00015	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GNAQ—melanoma	7.37e-06	0.000145	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CD44—melanoma	7.37e-06	0.000145	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP1B1—melanoma	7.06e-06	0.000139	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CB—melanoma	6.91e-06	0.000136	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—melanoma	6.85e-06	0.000135	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CG—melanoma	6.81e-06	0.000134	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—melanoma	6.57e-06	0.000129	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CD—melanoma	5.98e-06	0.000118	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTEN—melanoma	5.97e-06	0.000117	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—melanoma	5.91e-06	0.000116	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCB1—melanoma	5.82e-06	0.000114	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PRKCA—melanoma	5.35e-06	0.000105	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ERCC2—melanoma	5.31e-06	0.000104	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CB—melanoma	5.21e-06	0.000103	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—melanoma	5.17e-06	0.000102	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTEN—melanoma	4.51e-06	8.86e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CA—melanoma	4.21e-06	8.29e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CG—melanoma	4.19e-06	8.25e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—melanoma	4.05e-06	7.96e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CD—melanoma	3.69e-06	7.25e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—melanoma	3.64e-06	7.16e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKT1—melanoma	3.44e-06	6.77e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CB—melanoma	3.21e-06	6.32e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—melanoma	3.18e-06	6.26e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CA—melanoma	3.18e-06	6.25e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTEN—melanoma	2.78e-06	5.46e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKT1—melanoma	2.6e-06	5.11e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CA—melanoma	1.96e-06	3.85e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKT1—melanoma	1.6e-06	3.15e-05	CbGpPWpGaD
